Wyeth Pharms Inc Drug Patent Portfolio
Wyeth Pharms Inc owns 2 orange book drugs protected by 7 US patents Given below is the list of Wyeth Pharms Inc's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6500814 | Hormonal contraceptive | 03 Sep, 2018 | Expired |
| US5773001 | Conjugates of methyltrithio antitumor agents and intermediates for their synthesis | 30 Jun, 2015 | Expired |
| US5767285 | Linkers useful for the synthesis of conjugates of methyltrithio antitumor agents | 16 Jun, 2015 | Expired |
| US5739116 | Enediyne derivatives useful for the synthesis of conjugates of methyltrithio antitumor agents | 14 Apr, 2015 | Expired |
| US5693762 | Humanized immunoglobulins | 02 Dec, 2014 | Expired |
| US5606040 | Antitumor and antibacterial substituted disulfide derivatives prepared from compounds possessing a methyl-trithio group | 25 Feb, 2014 | Expired |
| US5585089 | Humanized immunoglobulins | 17 Dec, 2013 | Expired |
Wyeth Pharms Inc's Family Patents
Wyeth Pharms Inc Drug List
Given below is the complete list of Wyeth Pharms Inc's drugs and the patents protecting them.
1. Lybrel
Lybrel is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6500814 | Hormonal contraceptive |
03 Sep, 2018
(6 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Lybrel's drug page
2. Mylotarg
Mylotarg is protected by 6 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5773001 | Conjugates of methyltrithio antitumor agents and intermediates for their synthesis |
30 Jun, 2015
(9 years ago)
| Expired |
| US5767285 | Linkers useful for the synthesis of conjugates of methyltrithio antitumor agents |
16 Jun, 2015
(9 years ago)
| Expired |
| US5739116 | Enediyne derivatives useful for the synthesis of conjugates of methyltrithio antitumor agents |
14 Apr, 2015
(9 years ago)
| Expired |
| US5693762 | Humanized immunoglobulins |
02 Dec, 2014
(9 years ago)
| Expired |
| US5606040 | Antitumor and antibacterial substituted disulfide derivatives prepared from compounds possessing a methyl-trithio group |
25 Feb, 2014
(10 years ago)
| Expired |
| US5585089 | Humanized immunoglobulins |
17 Dec, 2013
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Mylotarg's drug page